Pediatric rheumatology

Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort

Pediatr Rheumatol Online JPublished Case-control study nested in the ReACCh-Out inception cohort

Authors' conclusion

Among newly diagnosed children with JIA with moderate pain, female sex, lower overall quality of life, and higher enthesitis counts at baseline predicted development of persisting pain.

Study context

Population
Newly diagnosed children with Juvenile Idiopathic Arthritis (JIA) and moderate pain, Canadian ReACCh-Out inception cohort
Participants
31 vs 118
Comparison
Moderate persisting pain vs moderate decreasing pain
  • Casesn = 31
  • Controlsn = 118reference
Outcome
Baseline predictors of persisting pain
Follow-up
Minimum 3 years
Methodological detailsunivariate and multivariate logistic regression, follow-up minimum 3 years
  • Univariate and multivariate logistic regression
  • Follow-up minimum 3 years

Main finding

As reported in the abstract

Baseline predictors of persisting pain (final multivariate model)

Enthesitis count at baseline, OR

1.40

95% CI 1.19–1.76

Female sex, OR

4.14

95% CI 1.33–16.83

Overall Quality of My Life (QoML) baseline score, OR

0.82

95% CI 0.69–0.98

Observational data: associations, not effects.

Further findings

Baseline characteristics

Female

RF-positive polyarthritis

Undifferentiated JIA

Oligoarthritis

Mean active joints Cases 11.4 · Controls 7.7

Sites of enthesitis Cases 4.6 · Controls 0.7

Mean

OutcomeCasesControls
Mean pain score at baseline6.4 (SD 1.6)5.9 (SD 1.5)

Original publication

Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort. Pediatr Rheumatol Online J. Published 16 September 2023. doi:10.1186/s12969-023-00885-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.